First microbiome-based drug clears phase III, in clinical trial turnaround
Ken Garber
Topics & Concepts
Clostridium difficileMicrobiomeMedicineDrugFood and drug administrationGut microbiomeClinical trialIntensive care medicineMicrobiologyPharmacologyBioinformaticsAntibioticsInternal medicineBiologyClostridium difficile and Clostridium perfringens researchGut microbiota and healthNosocomial Infections in ICU